Authors:
MITTERBAUER M
KUSEC R
SCHWARZINGER I
HAAS OA
LECHNER K
JAEGER U
Citation: M. Mitterbauer et al., COMPARISON OF KARYOTYPE ANALYSIS AND RT PCR FOR AML1 ETO IN 204 UNSELECTED PATIENTS WITH AML/, Annals of hematology, 76(3-4), 1998, pp. 139-143
Authors:
LACZIKA K
NOVAK M
HILGARTH B
MITTERBAUER M
MITTERBAUER G
SCHEIDELPETROVIC A
SCHOLTEN C
THALHAMMERSCHERRER R
BRUGGER S
KEIL F
SCHWARZINGER I
HAAS OA
LECHNER K
JAEGER U
Citation: K. Laczika et al., COMPETITIVE CBF-BETA MYH11 REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION FOR QUANTITATIVE ASSESSMENT OF MINIMAL RESIDUAL DISEASE DURING POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA WITH INVERSION(16) - A PILOT-STUDY/, Journal of clinical oncology, 16(4), 1998, pp. 1519-1525
Authors:
WELTERMANN A
MITTERBAUER GJ
MITTERBAUER M
HATTEY E
SPEISER W
GISSLINGER H
KNOBL P
EICHINGER S
Citation: A. Weltermann et al., DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT), Wiener Klinische Wochenschrift, 110(2), 1998, pp. 53-57
Authors:
MITTERBAUER G
SCHWARZMEIER J
MITTERBAUER M
JAEGER U
FRITSCH G
SCHWARZINGER I
Citation: G. Mitterbauer et al., MYELODYSPLASTIC SYNDROME ACUTE MYELOID-LEUKEMIA SUPERVENING PREVIOUSLY UNTREATED CHRONIC B-LYMPHOCYTIC LEUKEMIA - DEMONSTRATION OF THE CONCOMITANT PRESENCE OF 2 DIFFERENT MALIGNANT CLONES BY IMMUNOLOGICAL AND MOLECULAR ANALYSIS, Annals of hematology, 74(4), 1997, pp. 193-197
Authors:
SCHMID D
HEINZE G
LINNERTH B
TISLJAR K
KUSEC R
GEISSLER K
SILLABER C
LACZIKA K
MITTERBAUER M
ZOCHBAUER S
MANNHALTER C
HAAS OA
LECHNER K
JAGER U
GAIGER A
Citation: D. Schmid et al., PROGNOSTIC-SIGNIFICANCE OF WT1 GENE-EXPRESSION AT DIAGNOSIS IN ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA, Leukemia, 11(5), 1997, pp. 639-643
Authors:
MITTERBAUER M
FRITZERSZEKERES M
MITTERBAUER G
SIMONITSCH I
KNOBL P
RINTELEN C
SCHWARZINGER I
HAAS OA
SILBERBAUER K
FREY K
BIBUS B
PABINGER I
RADASZKIEWICZ T
LECHNER K
JAEGER U
Citation: M. Mitterbauer et al., SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA, Annals of hematology, 73(4), 1996, pp. 189-193
Authors:
THALHAMMER F
GEISSLER K
JAGER U
KYRLE PA
PABINGER I
MITTERBAUER M
GISSLINGER H
KNOBL P
LACZIKA K
SCHNEIDER B
HAAS OA
LECHNER K
Citation: F. Thalhammer et al., DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY, Annals of hematology, 72(4), 1996, pp. 216-222
Authors:
JAGER U
LACZIKA K
SCHOLTEN C
MITTERBAUER M
NOVAK M
LECHNER K
Citation: U. Jager et al., CLINICAL USE OF THE POLYMERASE CHAIN-REAC TION FOR DIAGNOSIS AND MONITORING OF MALIGNANT DISEASES, Wiener Klinische Wochenschrift, 108(20), 1996, pp. 634-639
Authors:
NOVAK M
LACZIKA K
HILGARTH B
SCHEIDELPETROVIC A
MITTERBAUER M
LECHNER K
JAEGER U
Citation: M. Novak et al., QUANTIFICATION OF CBF-BETA MYH11 FUSION TRANSCRIPTS BY COMPETITIVE RT-PCR POTENTIALLY PREDICTS PATIENT OUTCOME IN AML WITH INV(16)/, Blood, 88(10), 1996, pp. 2236-2236
Authors:
SCHOLTEN C
FODINGER M
MITTERBAUER M
LACZIKA K
MITTERBAUER G
HAAS OA
KNOBL P
SCHWARZINGER I
THALHAMMER R
PURTSCHER B
GEISSLER K
MANNHALTER C
LECHNER K
JAEGER U
Citation: C. Scholten et al., KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Annals of hematology, 71(4), 1995, pp. 155-160
Authors:
NOVAK M
LACZIKA K
MITTERBAUER M
PURTSCHER B
SCHEIDELPETROVIC A
LECHNER K
JAEGER U
Citation: M. Novak et al., NOVEL CBF-BETA-MYH11 FUSION TRANSCRIPTS AND ALTERNATIVE SPLICING IN ACUTE MYELOID-LEUKEMIA WITH INVERSION OF CHROMOSOME-16, Blood, 86(6), 1995, pp. 2449-2450
Authors:
NOVAK M
LACZIKA K
MITTERBAUER M
SCHEIDELPETROVIC A
HAAS OA
LECHNER K
JAEGER U
Citation: M. Novak et al., RT-PCR MONITORING OF CBF-BETA-MYH11 IN PATIENTS WITH AML AND A CHROMOSOMAL INV(16) - VARIABLE BEHAVIOR OF THE CHIMERIC MESSENGER-RNA DURINGTREATMENT, Blood, 86(10), 1995, pp. 1318-1318
Authors:
MITTERBAUER M
MITTERBAUER G
PIRCDANOEWINATA H
SCHWARZINGER I
KUSEC R
OHLER L
SCHWARZMEIER J
GEISSLER K
HAAS OA
LECHNER K
JAEGER U
Citation: M. Mitterbauer et al., PCR-DETECTION OF AML1 ETO CHIMERIC TRANSCRIPTS IN MYELODYSPLASTIC SYNDROMES WITHOUT PROGRESSION TO ACUTE-LEUKEMIA/, Blood, 86(10), 1995, pp. 3071-3071
Authors:
MITTERBAUER G
SCHWARZMEIER J
MITTERBAUER M
JAEGER U
FRITSCH G
SCHWARZINGER I
Citation: G. Mitterbauer et al., MYELODYSPLASTIC SYNDROME (MDS) SUPERVENING PREVIOUSLY UNTREATED CHRONIC B-CELL LEUKEMIA (B-CLL) - DEMONSTRATION OF CONCOMITANT PRESENCE OF A CD19+ IMMUNOGLOBULIN (IG)-REARRANGEMENT POSITIVE B-CELL CLONE AND A CD34+/AML1-ETO POSITIVE BLAST CELL CLONE/, Blood, 86(10), 1995, pp. 3180-3180
Authors:
MITTERBAUER M
KUSEC R
STROBL H
SCHEINECKER C
OEHLER L
SCHWARZINGER I
GEISSLER K
HAAS OA
KNAPP W
LECHNER K
Citation: M. Mitterbauer et al., LOCALIZATION OF AML1 ETO-TRANSCRIPTS IN A CD56+ LEUKOCYTE SUBSET AND IN THE CFU-GM PERIPHERAL STEM-CELL FRACTION IN PATIENTS WITH T(8-21)-POSITIVE ACUTE MYELOID-LEUKEMIA IN REMISSION/, Blood, 84(10), 1994, pp. 10000610-10000610